. Identification of Tal1 interaction partners using a biotin tag and SILAC based mass spectrometry. (A) Schematic representation of Tal1 fused to a birA-tag (green). Tal1 is biotinylated in K562 cells, which stably express the bir-Tal1 protein together with the birA-ligase. (B-D) Cells expressing the birA-Tal1 protein were grown in heavy (H) SILAC medium and control cells expressing the birA-ligase only were grown in light SILAC medium (L). Biotinylated Tal1 was pulled out from cell extracts using magnetic streptavidine beads (Dynabeads, M-280, Life Technologies). As a control a pulldown from cells expressing only the birA-ligase was performed. (C) BirA-Tal1 and the birA-control samples were combined, subjected to 1D-PAGE and coomassie stained. (D) Subsequently, the gel was cut into 23 slices. Upon tryptic digestion mass-spectrometric analysis was performed using a Q-exactive mass spectrometer. Resulting data sets were analyzed with the "MaxQuant" software
Supplementary Figure 4. Expression changes of genes involved in leukocyte differentiation or hematopoiesis. (A)
Expression data from the array analysis (as logFC differences) and changes upon Cl-amidine treatment (fold change compared to the control, SD gives the standard deviation). Green: upregulated, red: down regulated, grey: not significantly changed. Genes marked in blue had previously been shown to be direct Tal1 target genes in a distinct cellular background. (B) Expression changes upon knock down of Tal1 and PADI4 with an independent shRNA knock down measured by qRT-PCR. Potential Tal1 target genes (marked in blue above), were analyzed. Error bars give the standard deviation from at least four independent evaluations. Transduction was performed in two biological replicates Human primary CD34+ hematopoietic progenitor cells were isolated from peripheral blood mobilized with G-CSF using magnetic bead seperation. (B-E) Cells were subjected to megakaryocytic and erythroid differentiation, respectively. The differentiation efficiency was controlled by flow cytometry using a CD41 or GYPA (GPA) antibody. Furthermore, qPCR with primers against CD41 and beta-globin was performed. Error bars represent the standard deviation from at least four determinations. (F) For monocytic differentiation the cells were grown in monocytic differentiation medium and isolated by CD14 magnetic microbeads. The efficiency was controlled by flow cytometry using an anti-CD14 antibody. C-NMR (CD 3 OD, 300 MHz): 177. 2, 174.2, 170.3, 135.4, 133.0, 129.7, 128.4, 55.2, 54.2, 43.2, 40.3, 30.9, 29.2, 27. 
Tal1 interaction partners.
Supplementary Table 1. Tal1 interaction partners. Shown are the first 53 proteins identified by SILAC based mass spectrometry. The Tal1 interactome was defined as the proteins with an H/L ration higher than 5. In yellow Tal1 with an H/L ration of 17.92 and 15 unique identified peptides is shown. Proteins, which have previously shown to be part of a Tal1 complex, are displayed in dark grey. Novel interaction partners are highlighted in blue. PADI4 was identified with an H/L ratio of 6.74 and 4 unique peptides. Further, proteins are displayed between an H/L ratio of 5 and 1.5. The full list of identified peptides is shown in the supplementary excel file. Other known interaction partners of Tal1 such as GATA1 and LSD1 (KDM1A is no. 44 on our list) were not found significantly enriched in our analysis. 
